Topics
CNS Tumors | Overall management | Overview
Home > Publications > Topics > CNS Tumors > Overall management > Overview
*Guo E, Gupta M, Rossong H, Boone L, Manoranjan B, Ahmed S,
Stukalin I, Lama S, Sutherland GR.
Healthcare
spending versus mortality in central nervous system cancer: Has
anything changed?
Neurooncol
Pract. 2024 Apr 27;11(5):566-574. doi:
10.1093/nop/npae039. PMID:
39279779. Observational study˰
ˍ
Mlika M, Mokni M, Mezni F, Rammeh S.
Daily
management of gliomas, glioneuronal, and neuronal tumors in the
era of the 2021 WHO classification of nervous tumors.
Front
Neurol. 2024 Jul 29;15:1407572. doi:
10.3389/fneur.2024.1407572. PMID:
39135755. Perspective. ˍ
Tateishi K.
Translational Research
Platform for Malignant Central Nervous System Tumors.
Neurol
Med Chir (Tokyo). 2024 Aug 6. doi:
10.2176/jns-nmc.2024-0078. PMID:
39111869. Observational study. ˍ
Mittelbronn M.
Neurooncology: 2024
update.
Free
Neuropathol. 2024 Sep 27;4:21. doi:
10.17879/freeneuropathology-2024-5809. PMID:
39385753. Review. ˍ
**Magnon C.
What a wonderful world!
Genes
Dev. 2024 Oct 3;38(17-20):802-804. doi:
10.1101/gad.352278.124. PMID:
39362781. Meeting report. ˍ
Salomoni P.
Understanding brain cancer
and exploiting its vulnerabilities.
Mol
Oncol. 2024 Nov 25. doi:
10.1002/1878-0261.13769. PMID:
39582358. Editorial. ˍ
TRK fusion-driven primary CNS tumors
Lamoureux AA, Fisher MJ, Lemelle L, Pfaff E, Amir-Yazdani P, Kramm
C, De Wilde B, Kazanowska B, Hutter C, Pfister SM, Sturm D, Jones
DTW, Orbach D, Pierron G, Raskin S, Drilon A, Diamond EL, Harada
G, Zapotocky M, Zamecnik J, Krskova L, Ellezam B, Weil AG, Venne
D, Barritault M, Leblond P, Coltin H, Hammad R, Tabori U, Hawkins
C, Hansford JR, Meyran D, Erker C, McFadden K, Sato M, Gottardo
NG, Dholaria H, Nørøxe DS, Goto H, Ziegler DS, Lin
FY, Parsons DW, Lindsay H, Wong TT, Liu YL, Wu KS, Franson AT,
Hwang E, Aguilar-Bonilla A, Cheng S, Cacciotti C, Massimino M,
Schiavello E, Wood P, Hoffman LM, Cappellano A, Lassaletta A, Van
Damme A, Llort A, Gerber NU, Spalato Ceruso M, Bendel AE, Skrypek
M, Hamideh D, Mushtaq N, Walter A, Jabado N, Alsahlawi A, Farmer
JP, Coleman C, Mueller S, Mazewski C, Aguilera D, Robison NJ,
O'Halloran K, Abbou S, Berlanga P, Geoerger B, Øra I,
Moertel CL, Razis ED, Vernadou A, Ducray F, Bronnimann C, Seizeur
R, Clarke M, Resnick AC, Alves M, Jones C, Doz F, Laetsch TW,
Perreault S.
Clinical characteristics
and outcome of central nervous system
tumors harboring NTRK gene fusions.
Clin
Cancer Res. 2024 Dec 3. doi:
10.1158/1078-0432.CCR-24-0581. PMID:
39625867. Observational study. ˍ